Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells

Hiroyuki Michiue, Kazuhito Tomizawa, Masayuki Matsushita, Takashi Tamiya, Yun Fei Lu, Tomotsugu Ichikawa, Isao Date, Hideki Matsui

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Protein transduction therapy using poly-arginine can deliver the bioactive p53 protein into cancer cells and inhibits the proliferation of the cells. However, one disadvantage of such therapy is the short intracellular half-life of the delivered protein. Here, we generated mutant proteins in which multiple lysine residues in the C-terminal were substituted by arginines. The mutant proteins were effectively delivered in glioma cells and were resistant to Mdm2-mediated ubiquitination. Moreover, the mutant proteins displayed higher transcription regulatory activity and powerful inhibition of the proliferation of glioma cells. These results suggest that ubiquitination-resistant p53 protein therapy may become a new effective cancer therapy.

Original languageEnglish
Pages (from-to)3965-3969
Number of pages5
JournalFEBS Letters
Volume579
Issue number18
DOIs
Publication statusPublished - Jul 18 2005

Fingerprint

Ubiquitination
Glioma
Mutant Proteins
Growth
Arginine
Neoplasms
Proteins
Cell Proliferation
Transcription
Therapeutics
Lysine
Half-Life
Cells

Keywords

  • Brain tumor
  • Gene therapy
  • p53
  • Poly-arginine
  • TAT

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells. / Michiue, Hiroyuki; Tomizawa, Kazuhito; Matsushita, Masayuki; Tamiya, Takashi; Lu, Yun Fei; Ichikawa, Tomotsugu; Date, Isao; Matsui, Hideki.

In: FEBS Letters, Vol. 579, No. 18, 18.07.2005, p. 3965-3969.

Research output: Contribution to journalArticle

Michiue, Hiroyuki ; Tomizawa, Kazuhito ; Matsushita, Masayuki ; Tamiya, Takashi ; Lu, Yun Fei ; Ichikawa, Tomotsugu ; Date, Isao ; Matsui, Hideki. / Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells. In: FEBS Letters. 2005 ; Vol. 579, No. 18. pp. 3965-3969.
@article{7d4755b8d690421d88c3220555b36190,
title = "Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells",
abstract = "Protein transduction therapy using poly-arginine can deliver the bioactive p53 protein into cancer cells and inhibits the proliferation of the cells. However, one disadvantage of such therapy is the short intracellular half-life of the delivered protein. Here, we generated mutant proteins in which multiple lysine residues in the C-terminal were substituted by arginines. The mutant proteins were effectively delivered in glioma cells and were resistant to Mdm2-mediated ubiquitination. Moreover, the mutant proteins displayed higher transcription regulatory activity and powerful inhibition of the proliferation of glioma cells. These results suggest that ubiquitination-resistant p53 protein therapy may become a new effective cancer therapy.",
keywords = "Brain tumor, Gene therapy, p53, Poly-arginine, TAT",
author = "Hiroyuki Michiue and Kazuhito Tomizawa and Masayuki Matsushita and Takashi Tamiya and Lu, {Yun Fei} and Tomotsugu Ichikawa and Isao Date and Hideki Matsui",
year = "2005",
month = "7",
day = "18",
doi = "10.1016/j.febslet.2005.06.021",
language = "English",
volume = "579",
pages = "3965--3969",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "18",

}

TY - JOUR

T1 - Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells

AU - Michiue, Hiroyuki

AU - Tomizawa, Kazuhito

AU - Matsushita, Masayuki

AU - Tamiya, Takashi

AU - Lu, Yun Fei

AU - Ichikawa, Tomotsugu

AU - Date, Isao

AU - Matsui, Hideki

PY - 2005/7/18

Y1 - 2005/7/18

N2 - Protein transduction therapy using poly-arginine can deliver the bioactive p53 protein into cancer cells and inhibits the proliferation of the cells. However, one disadvantage of such therapy is the short intracellular half-life of the delivered protein. Here, we generated mutant proteins in which multiple lysine residues in the C-terminal were substituted by arginines. The mutant proteins were effectively delivered in glioma cells and were resistant to Mdm2-mediated ubiquitination. Moreover, the mutant proteins displayed higher transcription regulatory activity and powerful inhibition of the proliferation of glioma cells. These results suggest that ubiquitination-resistant p53 protein therapy may become a new effective cancer therapy.

AB - Protein transduction therapy using poly-arginine can deliver the bioactive p53 protein into cancer cells and inhibits the proliferation of the cells. However, one disadvantage of such therapy is the short intracellular half-life of the delivered protein. Here, we generated mutant proteins in which multiple lysine residues in the C-terminal were substituted by arginines. The mutant proteins were effectively delivered in glioma cells and were resistant to Mdm2-mediated ubiquitination. Moreover, the mutant proteins displayed higher transcription regulatory activity and powerful inhibition of the proliferation of glioma cells. These results suggest that ubiquitination-resistant p53 protein therapy may become a new effective cancer therapy.

KW - Brain tumor

KW - Gene therapy

KW - p53

KW - Poly-arginine

KW - TAT

UR - http://www.scopus.com/inward/record.url?scp=21844477537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844477537&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2005.06.021

DO - 10.1016/j.febslet.2005.06.021

M3 - Article

C2 - 15996664

AN - SCOPUS:21844477537

VL - 579

SP - 3965

EP - 3969

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 18

ER -